Nuvation Bio (NUVB) Goodwill & Intangibles: 2024-2025

Nuvation Bio's Goodwill & Intangibles rose 314.22% to $12.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $19.3 million, marking a year-over-year increase of 559.41%. This contributed to the annual value of $4.6 million for FY2024, which is N/A change from last year.
Per Nuvation Bio's latest filing, its Goodwill & Intangibles stood at $12.1 million for Q2 2025, which was up 175.40% from $4.4 million recorded in Q1 2025.
Nuvation Bio's 5-year Goodwill & Intangibles high stood at $12.1 million for Q2 2025, and its period low was $2.8 million during Q3 2024.
For the 2-year period, Nuvation Bio's Goodwill & Intangibles averaged around $5.6 million, with its median value being $3.7 million (2024).
Data for Nuvation Bio's Goodwill & Intangibles shows a peak YoY soared of 314.22% (in 2025) over the last 5 years.
Quarterly analysis of 2 years shows Nuvation Bio's Goodwill & Intangibles stood at $2.8 million in 2024, then soared by 314.22% to $12.1 million in 2025.
Its last three reported values are $12.1 million in Q2 2025, $4.4 million for Q1 2025, and $2.8 million during Q3 2024.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Goodwill & Intangibles (Qtr)
1	Summit Therapeutics Inc.	1,387.71B	1,387.50B	-	-
2	BeOne Medicines Ltd.	458.68B	457.16B	1.15B	-
3	Vertex Pharmaceuticals Inc / Ma	102.37B	99.35B	-	-
4	Benitec Biopharma Inc.	65.38B	65.31B	-	-
5	Regeneron Pharmaceuticals, Inc.	60.67B	60.28B	-	-
6	Alnylam Pharmaceuticals, Inc.	60.53B	62.66B	-	-
7	Argenx Se	45.96B	50.00B	-	-
8	INSMED Inc	26.50B	27.40B	-	-
9	BioNTech SE	25.15B	17.24B	-	-
10	Nuvation Bio Inc.	1.42B	1.38B	2.26M	-